title: Acute bidirectional manipulation of muscle glucose uptake by in vivo electrotransfer of constructs targeting glucose transporter genes.
abstract: Analysis of conventional germ-line or tissue-specific gene manipulation in vivo is potentially confounded by developmental adaptation of animal physiology. We aimed to adapt the technique of in vivo electrotransfer (IVE) to alter local gene expression in skeletal muscle of rodents as a means of investigating the role of specific proteins in glucose metabolism in vivo. We utilized a square-wave electroporator to induce intracellular electrotransfer of DNA constructs injected into rat or mouse muscles and investigated the downstream effects. In initial studies, expression of green fluorescent protein reporter was induced in 53 +/- 10% of muscle fibers peaking at 7 days, and importantly, the electrotransfer procedure itself did not impact upon the expression of stress proteins or our ability to detect a reduction in 2-deoxyglucose tracer uptake by electroporated muscle of high-fat-fed rats during hyperinsulinemic-euglycemic clamp. To demonstrate functional effects of electrotransfer of constructs targeting glucose transporters, we administered vectors encoding GLUT-1 cDNA and GLUT-4 short hairpin RNAs (shRNAs) to rodent muscles. IVE of the GLUT-1 gene resulted in a 57% increase in GLUT-1 protein, accompanied by a proportionate increase in basal 2-deoxyglucose tracer uptake into muscles of starved rats. IVE of vectors expressing two shRNAs for GLUT-4 demonstrated to reduce specific protein expression and 2-deoxyglucose tracer uptake in 3T3-L1 adipocytes into mouse muscle caused a 51% reduction in GLUT-4 protein, associated with attenuated clearance of tracer to muscle after a glucose load. These results confirm that glucose transporter expression is largely rate limiting for glucose uptake in vivo and highlight the utility of IVE for the acute manipulation of muscle gene expression in the study of the role of specific proteins in glucose metabolism.
authors.affiliation: Diabetes and Obesity Program, Garvan Institute of Medical Research, 384 Victoria St., Darlinghurst, NSW 2010, Australia. m.cleasby@garvan.org.au
authors.forename: Mark E
authors.initials: ME
authors.lastname: Cleasby
authors.forename: Jonathan R
authors.initials: JR
authors.lastname: Davey
authors.forename: Tracie A
authors.initials: TA
authors.lastname: Reinten
authors.forename: Michael W
authors.initials: MW
authors.lastname: Graham
authors.forename: David E
authors.initials: DE
authors.lastname: James
authors.forename: Edward W
authors.initials: EW
authors.lastname: Kraegen
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Cooney
mesh_terms: D000818:Animals; D001693:Biological Transport, Active; D002460:Cell Line; D018274:Electroporation; D005786:Gene Expression Regulation; D005947:Glucose / Q000378:metabolism*; D008297:Male; D051379:Mice; D009124:Muscle Proteins / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D009124:Muscle Proteins; D005947:Glucose